VICTORIA BURDEN: Open Payments
NPI 1023894425 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 34 payments from 14 companies in 2025. Trend: 2023 $24 · 2024 $551 · 2025 $886
Food & beverage: $787Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $277 |
| Astellas Pharma US Inc | 7 | $270 |
| Lilly USA, LLC | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| PFIZER INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: Wegovy, Veozah, Rybelsus, MOUNJARO, XIFAXAN, INSPIRE, SKYCLARYS, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
